MedPage Today on MSN

Medicare Decision on GLP-1s Soon; Inhaled Insulin Under Review for Kids; 'Manopause'

CMS Administrator Mehmet Oz, MD, MBA, said his agency will make an announcement on potential Medicare coverage of GLP-1 ...
MPR

FDA to Review Inhaled Insulin for Pediatric Diabetes

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

FDA accepts inhaled insulin application for pediatric use

( NewsNation) — Drugmaker MannKind announced that its inhaled insulin, Afrezza, has been approved for an application to help ...
The American Journal of Managed Care

Pediatric Atopic Dermatitis Treatment Selection: Biologics vs Nonsteroidal Topical Therapies

The recent FDA approval of topical JAK inhibitors for children 2 years or older marks a significant advancement in pediatric atopic dermatitis treatment. Previously approved only for individuals 12 ...